Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects

Authors:
  • SSShogo Sesoko
    Shogo Sesoko
  • MNMitsuyoshi Nakashima
    Mitsuyoshi Nakashima
  • NHNaoyuki Hayashi
    Naoyuki Hayashi
  • ATAtsushi Taniguchi
    Atsushi Taniguchi
  • YHYoshiharu Horie
    Yoshiharu Horie
  • EGEva U. Graefe-Mody
    Eva U. Graefe-Mody
  • HWHans-Juergen Woerle
    Hans-Juergen Woerle
  • KDKlaus A. Dugi
    Klaus A. Dugi

Abstract
No abstract available

This publication has 42 references indexed in Scilit: